Pure Global
NCT06270368

Children Born Preterm: Sustainable Health Monitoring

Meyer Children's Hospital IRCCS·ClinicalTrials.govRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Premature Birth
Study type
Observational
Sponsor & location
Primary sponsor
Meyer Children's Hospital IRCCS
Location
Firenze,Firenze,Pisa,Siena, Italy
Timeline & enrollment
Phase
N/A
Start date
Aug 05, 2020
End date
Dec 31, 2025
Enrollment
650 participants
Primary outcome

Infant development,Childhood development

Summary

Children born preterm are recognized to be at higher risk of short and long term
 complications and a formal follow-up of infants and children born preterm is recommended by
 international and national scientific societies. However, in Italy as well as in Tuscany,
 such a follow up is not usually done, and data are not collected in a structured way. The
 goal of this observational study is to evaluate the association between a large number of
 early life exposures and health outcomes and access to care during childhood in infants born
 preterm. The main questions it aims to answer are: • what is the role of prenatal and
 perinatal factors in influencing health outcomes during childhood in preterm infants? • What
 is the role of prenatal and perinatal factors in influencing access to care during childhood?
 Participants will be asked to attend a follow-up visit for the purpose of collecting health
 data.

ICD-10 classifications
Fetus and newborn affected by precipitate deliveryPreterm delivery without spontaneous labourDisorders related to short gestation and low birth weight, not elsewhere classifiedOther preterm infantsPreterm spontaneous labour with preterm delivery
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06270368
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06270368 through Pure Global AI's free database. This phase not specified trial is sponsored by Meyer Children's Hospital IRCCS and is currently Recruiting. The study focuses on Premature Birth. Target enrollment is 650 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.